Tapentadol Prolonged Release (PR) Versus Oxycodone/Naloxone Prolonged Release in Severe Chronic Low Back Pain With a Neuropathic Component.

Clinical trial NCT01838616 · COMPLETED

Trial details

NCT number: NCT01838616
Sponsor: Grünenthal GmbH
Status: COMPLETED
Phase: Phase 4
Study type: INTERVENTIONAL

Back Pain Low Back Pain Neuropathic Pain

Start date: 2013-04-01
Primary completion: 2014-01-01
Enrollment: 367

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.